ValueRx GI disease management drug spend could drop 30% for specific client.
Executive Summary
VALUERx GI DISEASE MANAGEMENT DRUG SPEND COULD FALL 30% for one of the pharmacy benefit manager's biggest clients, according to company projections based on previous physician education programs, ValueRx said June 20. ValueRx' gastrointestinal disease management program was initiated for the client in the first quarter of this year, ValueRx reported, and should have results that can be analyzed in the autumn.